Dhanuka Agritech FY26 Net Profit ₹2,872 Cr; Approves ₹70 Cr Buyback

Dhanuka Agritech held its Board of Directors meeting on May 19, 2026, approving the audited financial results for the quarter and financial year ended March 31, 2026. The statutory auditors, S S Kothari Mehta & Co. LLP, issued an unmodified opinion on the audited financial results. The board meeting commenced at 11:00 A.M. (IST) and concluded at 1:05 P.M. (IST).

Financial Performance

Dhanuka Agritech reported its audited financial results for the quarter and full year ended March 31, 2026. The following table presents the key financial metrics (₹ in Lacs):

Metric: Q4 FY26 (Audited) Q3 FY26 (Unaudited) Q4 FY25 (Audited) FY26 (Audited) FY25 (Audited) Revenue from Operations: 48,333.67 40,991.67 44,202.32 2,01,978.96 2,03,515.18 Other Income: 2,052.64 812.38 1,115.56 4,301.14 3,610.49 Total Income: 50,386.31 41,804.05 45,317.88 2,06,280.10 2,07,125.67 Total Expenses: 37,555.17 36,830.93 35,151.64 1,68,424.03 1,67,911.60 Profit Before Tax: 12,831.14 4,973.12 10,166.24 37,856.07 39,214.07 Net Profit: 9,777.06 3,999.54 7,550.23 28,723.49 29,696.03 Total Comprehensive Income: 9,870.90 3,999.54 7,691.26 28,817.33 29,837.06 Basic EPS (₹): 21.69 8.87 16.74 63.72 65.55 Diluted EPS (₹): 21.69 8.87 16.74 63.72 65.55

The company operates in a single reportable business segment — Agro Chemicals. The Board noted that demand for the company's products is influenced by monsoon patterns, pest infestation, and crop cycles, which may result in period-to-period variations in results.

Balance Sheet Highlights

The audited balance sheet as at March 31, 2026 reflects the following key positions (₹ in Lacs):

Parameter: Mar 31, 2026 (Audited) Mar 31, 2025 (Audited) Total Non-Current Assets: 58,468.45 65,155.32 Total Current Assets: 1,51,733.84 1,14,856.04 Total Assets: 2,10,202.29 1,80,011.36 Total Equity: 1,68,187.87 1,40,272.11 Total Non-Current Liabilities: 4,955.74 4,881.03 Total Current Liabilities: 37,058.68 34,858.22 Other Equity: 1,67,286.30 1,39,370.54

The company's cash and cash equivalents stood at ₹1,893.48 lacs as at March 31, 2026, compared to ₹57.00 lacs in the prior year. Net cash from operating activities for the year was ₹19,620.07 lacs, while net cash used in investing activities was ₹11,804.88 lacs. Net cash used in financing activities was ₹5,978.71 lacs, resulting in a net increase of ₹1,836.48 lacs in cash and cash equivalents during the year.

Buyback of Equity Shares

The Board approved a buyback of fully paid-up equity shares through the Tender Offer route under the SEBI (Buyback of Securities) Regulations, 2018. Key details of the buyback are as follows:

Parameter: Details Number of Shares: Up to 5,00,000 (Five Lakhs) equity shares % of Paid-Up Capital: 1.11% Buyback Price: ₹1,400 per equity share Aggregate Offer Size: Up to ₹70 Crore Route: Tender Offer via stock exchange mechanism Record Date: Friday, May 29, 2026

The maximum buyback size excludes transaction costs such as brokerage, fees, applicable taxes, and other incidental expenses. The Board also noted the intention of the Promoters and Promoter Group to participate in the proposed buyback. The Board may, until one working day prior to the record date, increase the maximum buyback price and correspondingly decrease the number of shares, provided the aggregate offer size remains unchanged. The public announcement and related statutory documents will be released in due course.

Final Dividend and Annual General Meeting

The Board recommended a final dividend of 100%, i.e., ₹2 per equity share of face value ₹2 each, for FY26, subject to shareholder approval at the ensuing 41st Annual General Meeting (AGM). The record date for dividend eligibility has been fixed as Friday, July 17, 2026, and the cut-off date for AGM voting purposes is Monday, July 27, 2026. The 41st AGM is scheduled for Monday, August 3, 2026, at 11:00 AM via Video Conferencing or Other Audio Visual Means. The dividend will be paid within 30 days of the AGM.

Employee Benefit Schemes

The Board approved two new employee benefit schemes, both subject to member approval at the 41st AGM:

Dhanuka Employee Stock Option Plan 2026 (ESOP Scheme 2026): Up to 50,000 stock options may be granted, exercisable into up to 50,000 equity shares of face value ₹2 each, representing 0.11% of the equity share capital. The exercise period commences from the date of vesting of the first tranche and shall not extend beyond eight years from the grant date. The minimum vesting period is one year.

Dhanuka Stock Appreciation Rights Plan 2026 (SAR Scheme 2026): Up to 1,25,000 SARs may be granted, representing 0.28% of the equity share capital. The exercise period similarly commences from the date of vesting of the first tranche and shall not extend beyond eight years from the grant date, with a minimum vesting period of one year.

Both schemes are in compliance with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, and the pricing for grants will be determined by the Board or Nomination and Remuneration Committee at the time of grant.

International Expansion and Other Corporate Actions

The Board approved the establishment of wholly owned subsidiaries or acquisition of shares of companies outside India in Brazil and a European country. The initial investment limit is ₹1 Crore per entity, which may be increased subject to Board approval and applicable regulatory requirements. The purpose of these entities is to support the transfer of brand registrations acquired from Bayer and to register various other products in the company's name in those markets. Both entities will operate in the agro-chemical business.

Additionally, the Board re-appointed M/s. N Khandelwal & Co., Cost Accountants, as Cost Auditors for FY2026-27. The Board also took note of the retirement of Mr. K.B. Kejariwal, Senior Management Personnel, upon attaining superannuation with effect from the close of business hours on March 31, 2026, and placed on record its appreciation for his contributions.

The Board further noted that the incremental impact of the four Labour Codes notified by the Government of India on November 21, 2025, amounts to ₹598.68 lakhs, primarily on account of changes in wage definition under the Code on Wages. This impact has been recognised in employee benefits expense for the year ended March 31, 2026. As of the reporting date, the company has no subsidiaries, joint ventures, or associate companies, and accordingly, consolidated financial results are not required under Regulation 33 of the SEBI Listing Regulations.